Literature DB >> 10791765

IGF and insulin action in the mammary gland: lessons from transgenic and knockout models.

D L Hadsell1, S G Bonnette.   

Abstract

Transgenic and knockout mice have become valuable experimental systems with which to study specific molecular events within the mammary gland of an intact animal. These models have provided a wealth of information about the effects of a number of oncogenes and growth factors. This review focuses on results obtained from the application of transgenic and knockout models to determine the roles of insulin and insulin-like growth factors (IGF) in the regulation of mammary gland development, lactation and tumorigenesis. Transgenic models which overexpress IGF-I or -II display specific alterations in mammary gland development and an increased incidence of mammary tumors. Analysis of mammary gland development in knockout mice which are deficient in IGF-I or the IGF-I receptor supports the conclusion that the IGF system is important for normal mammary gland development. This review discusses these observations in detail and attempts to fit them into a larger picture of IGF and insulin action in the mammary gland.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10791765     DOI: 10.1023/a:1009559014703

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  69 in total

Review 1.  Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.

Authors:  A Virkamäki; K Ueki; C R Kahn
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

2.  14-3-3 proteins interact with the insulin-like growth factor receptor but not the insulin receptor.

Authors:  R W Furlanetto; B R Dey; W Lopaczynski; S P Nissley
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

3.  Identification of signalling components in tyrosine kinase cascades using phosphopeptide affinity chromatography.

Authors:  G Duménil; M Rubini; G Dubois; R Baserga; M Fellous; S Pellegrini
Journal:  Biochem Biophys Res Commun       Date:  1997-05-29       Impact factor: 3.575

4.  Ligand-inducible and liver-specific target gene expression in transgenic mice.

Authors:  Y Wang; F J DeMayo; S Y Tsai; B W O'Malley
Journal:  Nat Biotechnol       Date:  1997-03       Impact factor: 54.908

5.  Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I), IGF-II and des(1-3)IGF-I in rats.

Authors:  F J Ballard; S E Knowles; P E Walton; K Edson; P C Owens; M A Mohler; B L Ferraiolo
Journal:  J Endocrinol       Date:  1991-02       Impact factor: 4.286

6.  Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting.

Authors:  E M Bailyes; B T Navé; M A Soos; S R Orr; A C Hayward; K Siddle
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

7.  Investigation of the mechanism of action of growth hormone in stimulating lactation in the rat.

Authors:  D J Flint; E Tonner; J Beattie; D Panton
Journal:  J Endocrinol       Date:  1992-09       Impact factor: 4.286

8.  Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice.

Authors:  C E Rogler; D Yang; L Rossetti; J Donohoe; E Alt; C J Chang; R Rosenfeld; K Neely; R Hintz
Journal:  J Biol Chem       Date:  1994-05-13       Impact factor: 5.157

9.  Differential signalling potential of insulin- and IGF-1-receptor cytoplasmic domains.

Authors:  R Lammers; A Gray; J Schlessinger; A Ullrich
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

10.  Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development.

Authors:  J J Wysolmerski; J F McCaughern-Carucci; A G Daifotis; A E Broadus; W M Philbrick
Journal:  Development       Date:  1995-11       Impact factor: 6.868

View more
  27 in total

Review 1.  Establishing a framework for the functional mammary gland: from endocrinology to morphology.

Authors:  Russell C Hovey; Josephine F Trott; Barbara K Vonderhaar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

Review 2.  Inhibitors of insulin-like growth factor signaling: a therapeutic approach for breast cancer.

Authors:  Deepali Sachdev; Douglas Yee
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-01       Impact factor: 2.673

3.  IGFBP3 polymorphisms and risk of cancer: a meta-analysis.

Authors:  Li Li; Xin Huang; Keke Huo
Journal:  Mol Biol Rep       Date:  2009-05-18       Impact factor: 2.316

4.  The IGF system in mammary development and breast cancer. Preface.

Authors:  Douglas Yee; Teresa L Wood
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-12       Impact factor: 2.673

Review 5.  Role of insulin-like growth factor binding proteins in mammary gland development.

Authors:  D J Flint; E Tonner; J Beattie; G J Allan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-08       Impact factor: 2.673

6.  PTEN overexpression suppresses proliferation and differentiation and enhances apoptosis of the mouse mammary epithelium.

Authors:  Joëlle Dupont; Jean Pierre Renou; Moshe Shani; Lothar Hennighausen; Derek LeRoith
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

Review 7.  Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Authors:  David L Kleinberg; Teresa L Wood; Priscilla A Furth; Adrian V Lee
Journal:  Endocr Rev       Date:  2008-12-15       Impact factor: 19.871

8.  Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells.

Authors:  Kristopher C Carver; Timothy M Piazza; Linda A Schuler
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

9.  Pubertal exposure to high fat diet causes mouse strain-dependent alterations in mammary gland development and estrogen responsiveness.

Authors:  L K Olson; Y Tan; Y Zhao; M D Aupperlee; S Z Haslam
Journal:  Int J Obes (Lond)       Date:  2010-03-16       Impact factor: 5.095

10.  The protective effect of intermittent calorie restriction on mammary tumorigenesis is not compromised by consumption of a high fat diet during refeeding.

Authors:  Olga P Rogozina; Katai J Nkhata; Emily J Nagle; Joseph P Grande; Margot P Cleary
Journal:  Breast Cancer Res Treat       Date:  2013-02-28       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.